Evidence map›Paper›PMID 38811574›Full record

ArticleScientific reports2024

Respiratory muscle strength can improve the prognostic assessment in COPD.

Rebeca Nunes Silva, Cássia da Luz Goulart, Claudio R de Oliveira, Renata Gonçalves Mendes, Ross Arena, Jonathan Myers, Audrey Borghi-Silva

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Respiratory Muscle Strength and Mortality in Patients with COPD: A Systematic Review and Meta-Analysis.International journal of chronic obstructive pulmonary disease · 2025
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rebeca Nunes SilvaDepartment of Physiotherapy, Cardiopulmonary Physiotherapy Laboratory (LACAP), Federal University of São Carlos (UFSCar), São Carlos, São Paulo, 13565-905, Brazil.
Cássia da Luz GoulartDepartment of Physiotherapy, Cardiopulmonary Physiotherapy Laboratory (LACAP), Federal University of São Carlos (UFSCar), São Carlos, São Paulo, 13565-905, Brazil.
Claudio R de OliveiraDepartment of Medicine, Federal University of São Carlos (UFSCar), São Carlos, São Paulo, Brazil.
Renata Gonçalves MendesDepartment of Physiotherapy, Cardiopulmonary Physiotherapy Laboratory (LACAP), Federal University of São Carlos (UFSCar), São Carlos, São Paulo, 13565-905, Brazil.
Ross ArenaDepartment of Physical Therapy, College of Applied Health Sciences, University of Illinois Chicago, Chicago, IL, USA.
Jonathan MyersVeterans Affairs Palo Alto HealthCare System, Stanford University, Palo Alto, CA, USA.
Audrey Borghi-SilvaDepartment of Physiotherapy, Cardiopulmonary Physiotherapy Laboratory (LACAP), Federal University of São Carlos (UFSCar), São Carlos, São Paulo, 13565-905, Brazil. audrey@ufscar.br.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior CAPES-001Sao Paulo Research Foundation (FAPESP) #2015/26501-1
6 · The paper itself

Abstract

Impaired lung function, respiratory muscle weakness and exercise intolerance are present in COPD and contribute to poor prognosis. However, the contribution of the combination of these manifestations to define prognosis in COPD is still unknown. This study aimed to define cut-off points for both inspiratory and expiratory muscle strength (MIP and MEP, respectively) for mortality prediction over 42-months in patients with COPD, and to investigate its combination with other noninvasive established prognostic measures (FEV

Indexed as

Muscle StrengthPulmonary Disease, Chronic ObstructiveRespiratory MusclesAgedExercise TestFemaleHumansMaleMiddle AgedPrognosisRespiratory Function Tests

Identifiers

PMID38811574
PMCPMC11137089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.